The global digital therapeutics market size is estimated to be USD 2,951.1 million in 2021 and is expected to grow a CAGR of 21.86% during the forecast period. Technological advancements in products, government initiatives to provide improved healthcare services, adoption of smart technology by consumers, and growing need to minimize healthcare costs are major factors that are expected to propel the global market growth. However, patient data privacy issues, unsecured payment gateways, lack of awareness, and unavailability of explicit training programs for digital therapeutics in emerging economies are expected to hinder the growth.

By Application

Based on application, the market is categorized into nutrition, diabetes, central nervous system disorder, cardiovascular diseases, respiratory disorders, musculoskeletal disorders, gastrointestinal disorders, drug addiction, and others. In 2021, diabetes segment accounted for the highest revenue share. This is due to the growing prevalence of diabetes coupled with rising need for cost-effective personalized diabetic treatment worldwide. The nutrition segment is estimated to grow with a significant CAGR during the forecast period owing to the presence of a large number of obese population base that may result in chronic diseases.

By Product Type

Based on product type, the market is segmented into hardware and software. In 2021, the hardware segment accounted for a significant revenue share owing to its larger penetration and adoption among B2B and B2C users. The software segment is projected to grow at a lucrative CAGR during the forecast period owing to increasing R&D in medical software sector.

By EndUse

On the basis of enduse, the market is categorized into Business-to-Business (B2B) and Business-to-Consumers segment (B2C). The B2B segment is subsegmented into employers, hospitals, pharmaceutical firms, and others. This segment accounted for the largest revenue share in 2021 owing to the increasing application of digital therapeutics to provide cost-effective and faster care to patients. The B2C segment is subdivided into patients and caregivers.

Regional Insights

North America was the highest revenue-grossing segment of the global market in 2021 and is projected to maintain its dominance during the forecast period. This is due to high adoption of patient-centric medical solutions and rapidly rising demand to reduce the healthcare facility’s maintenance expenses in this region. Asia Pacific is estimated to grow at the fastest growth rate during the forecast period owing to the increasing adoption of digital technology in healthcare sector, significant funding by venture capitalists & government in medical infrastructure, and rising prevalence of chronic diseases including diabetes and obesity.

Competitor Insights

Some of the major companies in the digital therapeutics market are Noom, Inc. (U.S.), Fitbit, Inc. (U.S.), TrialCard Incorporated (U.S.), ResMed (U.S.), Canary Health, Inc. (U.S.), Medtronic PLC (Ireland), WellDoc, Inc. (U.S.), Omada Health, Inc. (U.S.), Mitsubishi Chemical Holdings (Japan), and Novartis International AG (Switzerland). Strategic partnership, mergers, investment in R&D, and geographic expansion are some of the major strategies adopted by the leading players operating in the industry.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The digital therapeutics market report is categorized into the following segments and subsegments:

Digital Therapeutics Market, By Application (Revenue, 2021-2029, USD Million)

Digital Therapeutics Market, By Product Type (Revenue, 2021-2029, USD Million)

Digital Therapeutics Market, By End-User (Revenue, 2021-2029, USD Million)

Digital Therapeutics Market, By Region (Revenue, 2021-2029, USD Million)

Scope of Digital Therapeutics Market Report:

Key Parameters	Details
Base Year	2021
Forecast Period	2022-2029
Study Coverage	Global and regional market size and revenue forecast Segment market size and revenue forecast at global, regional, and country level Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis) Conclusion and recommendations
Qualitative Analysis	Market drivers Market restraints Market opportunities Recent market trends Market challenges Porter’s Five Forces analysis PEST analysis Value-chain analysis COVID-19 impact analysis
Regional Market Scope	North America (U.S. and Canada) Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC) Latin America (Brazil, Mexico, Argentina, Rest of LATAM) MEA (South Africa, GCC, Rest of MEA)
Company Profiles	Exhaustive profiles of top 10 players 50+ other major players listing
15% Free Customization Available	You can customize the study scope to meet your exact requirement. Click here for more details